NO20031413D0 - Ny fremgangsmåte for fremstilling av oksabispidiner - Google Patents

Ny fremgangsmåte for fremstilling av oksabispidiner

Info

Publication number
NO20031413D0
NO20031413D0 NO20031413A NO20031413A NO20031413D0 NO 20031413 D0 NO20031413 D0 NO 20031413D0 NO 20031413 A NO20031413 A NO 20031413A NO 20031413 A NO20031413 A NO 20031413A NO 20031413 D0 NO20031413 D0 NO 20031413D0
Authority
NO
Norway
Prior art keywords
oxabispidines
production
new process
new
Prior art date
Application number
NO20031413A
Other languages
English (en)
Other versions
NO20031413L (no
Inventor
John Pavey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2000/001994 external-priority patent/WO2001028992A2/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20031413D0 publication Critical patent/NO20031413D0/no
Publication of NO20031413L publication Critical patent/NO20031413L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031413A 2000-10-02 2003-03-27 Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt NO20031413L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PH12000002701 2000-10-02
PCT/SE2000/001994 WO2001028992A2 (en) 1999-10-18 2000-10-13 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
PCT/SE2001/002130 WO2002028864A1 (en) 2000-10-02 2001-10-01 New process for the production of oxabispidines

Publications (2)

Publication Number Publication Date
NO20031413D0 true NO20031413D0 (no) 2003-03-27
NO20031413L NO20031413L (no) 2003-05-22

Family

ID=52573779

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20031413A NO20031413L (no) 2000-10-02 2003-03-27 Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
NO20031414A NO20031414L (no) 2000-10-02 2003-03-27 Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20031414A NO20031414L (no) 2000-10-02 2003-03-27 Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier

Country Status (22)

Country Link
US (5) US6936712B1 (no)
EP (3) EP1330462A1 (no)
JP (2) JP2004510775A (no)
KR (2) KR20030032060A (no)
CN (3) CN1793146A (no)
AR (1) AR030756A1 (no)
AU (3) AU2001292503A1 (no)
BR (2) BR0114367A (no)
CA (2) CA2421776A1 (no)
CZ (1) CZ294217B6 (no)
EE (1) EE200300131A (no)
HU (1) HUP0302288A3 (no)
IL (3) IL154803A0 (no)
IS (1) IS6744A (no)
MX (2) MXPA03002759A (no)
NO (2) NO20031413L (no)
NZ (2) NZ524574A (no)
PL (1) PL364047A1 (no)
RU (1) RU2003107668A (no)
SK (1) SK3862003A3 (no)
WO (2) WO2002028864A1 (no)
ZA (2) ZA200301757B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CA2609938A1 (en) 2005-06-13 2006-12-21 Astrazeneca Ab New oxabispidine compounds for the treatment of cardiac arrhythmias
WO2006137771A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of sulfonic acid salts of oxabispidines
EP1896486A4 (en) * 2005-06-20 2010-11-03 Astrazeneca Ab PROCESS FOR THE PREPARATION OF 3,7-DIHYDROXY-1,5-DIAZACYCLOOCTANESE
AR057363A1 (es) * 2005-06-20 2007-11-28 Astrazeneca Ab Proceso para la preparacion de oxabispidinas n,n'-disustituidas
WO2006137772A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab New physical form of n,n´- disubstituted oxabispidines
CN103319423B (zh) * 2013-06-28 2015-10-28 江苏师范大学 一种3,7-双芳基-1,5-二氧-3,7-二氮杂环辛烷的合成方法
KR20150082070A (ko) 2014-01-06 2015-07-15 (주)신비넷 위치 인식 시스템 및 그 시스템에서의 위치 인식을 위한 장치 및 방법
EP3059229A1 (en) 2015-02-17 2016-08-24 Evonik Degussa GmbH Method for the epoxidation of an olefin with hydrogen peroxide
CN115054728B (zh) * 2022-07-18 2023-11-07 中国科学院大学宁波华美医院 一种仿生骨组织工程支架材料及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3503939A (en) * 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
DE3112055A1 (de) * 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
DE3732094A1 (de) * 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
DE3902357A1 (de) 1989-01-27 1990-08-02 Hoechst Ag Verwendung von rheniumorganischen verbindungen zur oxidation von c-c-mehrfachbindungen, darauf basierende oxidationsverfahren und neue rheniumorganische verbindungen
US5140033A (en) * 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) * 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
US5831099A (en) 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
US5939568A (en) 1997-01-31 1999-08-17 The Scripps Research Institute Accelerated catalysis of olefinic epoxidations
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
HUP0202214A3 (en) * 1999-04-09 2002-12-28 Astrazeneca Ab Adamantane derivatives, preparation and use thereof
AUPQ274199A0 (en) 1999-09-09 1999-09-30 Ericsson Australia Pty Ltd Information transmission rate control across a core network
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
GB0223712D0 (en) * 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate

Also Published As

Publication number Publication date
CN1243754C (zh) 2006-03-01
JP4248873B2 (ja) 2009-04-02
US20090240051A1 (en) 2009-09-24
KR20030032060A (ko) 2003-04-23
HUP0302288A2 (hu) 2003-10-28
ZA200302202B (en) 2004-06-28
NZ524574A (en) 2004-11-26
JP2004510776A (ja) 2004-04-08
PL364047A1 (en) 2004-12-13
US20040039199A1 (en) 2004-02-26
US6936712B1 (en) 2005-08-30
WO2002028864A1 (en) 2002-04-11
EP1900741A1 (en) 2008-03-19
AU2001292503A1 (en) 2002-04-15
KR20030032061A (ko) 2003-04-23
US20090036675A1 (en) 2009-02-05
JP2004510775A (ja) 2004-04-08
BR0114366A (pt) 2003-08-12
WO2002028863A8 (en) 2003-06-05
RU2003107668A (ru) 2004-11-27
CA2421776A1 (en) 2002-04-11
KR100812920B1 (ko) 2008-03-11
SK3862003A3 (en) 2003-10-07
NO20031414D0 (no) 2003-03-27
AU9250401A (en) 2002-04-15
CN1468245A (zh) 2004-01-14
CN1468244A (zh) 2004-01-14
US20050171100A1 (en) 2005-08-04
IL154802A0 (en) 2003-10-31
MXPA03002759A (es) 2003-07-28
NO20031414L (no) 2003-05-26
IL154803A0 (en) 2003-10-31
NZ524573A (en) 2004-11-26
WO2002028863A1 (en) 2002-04-11
NO20031413L (no) 2003-05-22
BR0114367A (pt) 2003-12-09
CA2422810A1 (en) 2002-04-11
IL154803A (en) 2008-03-20
AU2001292504B2 (en) 2006-09-07
CN1793146A (zh) 2006-06-28
EP1330462A1 (en) 2003-07-30
ZA200301757B (en) 2004-02-05
AR030756A1 (es) 2003-09-03
HUP0302288A3 (en) 2004-11-29
US7439355B2 (en) 2008-10-21
EP1900741A8 (en) 2010-08-04
CZ2003923A3 (cs) 2003-08-13
EE200300131A (et) 2003-06-16
MXPA03002679A (es) 2003-06-24
EP1330461A1 (en) 2003-07-30
CZ294217B6 (cs) 2004-10-13
IS6744A (is) 2003-03-13

Similar Documents

Publication Publication Date Title
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20010146L (no) Fremgangsmåte for ökning av hydrokarbonproduksjon
NO20013943D0 (no) Fremgangsmate for fremstilling av Citalopram
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20026116L (no) Fremgangsmåte for fremstilling av blokkskum
NO20033267D0 (no) Fremgangsmåter for öket produksjon av av pantothenat
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
FI20011541A0 (fi) Menetelmä massan valmistamiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
AR028078A1 (es) Proceso para la produccion de grrnulos de enzimas
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
NO20035411D0 (no) Fremgangsmåte for fremstilling av forbedret papirmasse
DE60107191D1 (de) Herstellung von 2-Hydrocarbyl-2-Adamantylacrylaten
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
TR200003585A3 (tr) Vinilaromatik polimerlerin üretimi için islem
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
DK1274677T3 (da) Fremgangsmåde til fremstilling af oximethere
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application